Mécanismes de la production d'anions superoxydes par les polynucléaires neutrophiles humains. Analyse par la starosporine, un inhibiteur de protéines kinases = Mechanisms of superoxide anion production by human polymorphonuclear neutrophils. Investigation with staurosporine, a protein kinase inhibitorCOMBADIERE, Christophe; HAKIM, Jacques.1993, 226 p.Thesis

Comparaison des effets biologiques du radical hydroxyle généré par la réaction de Fenton ou par la radiolyse de l'eau = Biological effects of hydroxyl radical produced by the iron-driven Fenton reaction or by water radiolysisCatry-Franzini, Elisabeth; Hakim, Jacques.1993, 194 p.Thesis

Rôle de la protéine Kinase C Cytosolique dans les activités fonctionnelles des polynucléaires neutrophiles humainsGaudry, Murielle; Hakim, Jacques.1989, 230 p.Thesis

Etude des granulocytes : aspects physiopathologiquesPham Huu, Trung; Hakim, Jacques.1987, 255 p.Thesis

RECHERCHE SUR LA CYTOTOXICITE ET LE POUVOIR CANCERIGENE DES POLLUANTS ATMOSPHERIQUES GAZEUX OU PARTICULAIRES = RESEARCH INVOLVING THE CYTOTOXICITY AND THE CARCINOGENICITY OF GASEOUS OR PARTICULATE ATMOSPHERIC POLLUTANTSHAKIM JACQUES.sd; FRA; DA. S.D.; ENV-MER/77085; 5 P.; 30 CM; MILIEUX PHYSIQUES: AIRReport

Caractérisation de l'inhibition fonctionnelle des polynucléaires neutrophiles humains par un facteur produit par des cellules cancéreuses (lignée CML K562) = Characterization of functional inhibitions of human polymorphonuclear neutrophils by a factor produced by K562 malignant cellsAmar, Michèle; Hakim, Jacques.1991, 212 p.Thesis

Processus oxydants et réponses immunitaires : mécanismes biochimiques et cellulairesGougerot-Pocidalo, Marie-Anne; Hakim, Jacques.1988, 197 p.Thesis

Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypassDHOTE-BURGER, P; VUILLEMINOT, A; LECOMPTE, T et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S124-S129, issn 0160-2446, SUP2Conference Paper

Pentoxifylline for the treatment of HIV infection and its complicationsDEZUBE, B. J; LEDERMAN, M. M.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S139-S142, issn 0160-2446, SUP2Conference Paper

Pharmacologic approaches to the treatment of atherosclerotic arterial obstructionCAPRON, L.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S40-S43, issn 0160-2446, SUP2Conference Paper

From cyclic AMP to cytokines. Pentoxifylline : present and future. International congressCAPRON, Loic; HAKIM, Jacques; WAUTIER, Jean-Luc et al.Journal of cardiovascular pharmacology. 1995, Vol 25, issn 0160-2446, 152 p., SUP2Conference Proceedings

Cytokines and thrombosisDOSQUET, C; WEILL, D; WAUTIER, J.-L et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S13-S19, issn 0160-2446, SUP2Conference Paper

Effect of pentoxifylline on apoptosis of cultured cellsBELLOC, F; JALOUSTRE, C; DUMAIN, P et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S71-S74, issn 0160-2446, SUP2Conference Paper

Pentoxifylline and lung ischemia-reperfusion injury : Application to lung transplantationCHAPELIER, A; REIGNIER, J; MAZMANIAN, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S130-S133, issn 0160-2446, SUP2Conference Paper

Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cellsBENBERNOU, N; ESNAULT, S; POTRON, G et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S75-S79, issn 0160-2446, SUP2Conference Paper

Expression of elastase and fibrin in venous leg ulcer biopsies : a pilot study of pentoxifylline versus placeboMIRSHAHI, S; SORIA, J; MIRSHAHI, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S101-S105, issn 0160-2446, SUP2Conference Paper

Impairment of polymorphonuclear neutrophil function in HIV-infected patientsELBIM, C; PREVOT, M. H; BOUSCARAT, F et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S66-S70, issn 0160-2446, SUP2Conference Paper

Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shockBARROSO-ARANDA, J; ZWEIFACH, B. W; MATHISON, J. C et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S23-S29, issn 0160-2446, SUP2Conference Paper

Pentoxifylline and intermittent claudication : Review of clinical trials and cost-effectiveness analysesGILLINGS, D. B.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S44-S50, issn 0160-2446, SUP2Conference Paper

Cytokines regulate vascular functions related to stability of the atherosclerotic plaqueLIBBY, P; SUKHOVA, G; LEE, R. T et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S9-S12, issn 0160-2446, SUP2Conference Paper

Inhibitors of phosphodiesterase (pentoxifylline, trequinsin) inhibit apical and subcellular matrix expression of tissue factor in cultured human endothelial cellsLECLERC, N. E; HAAN-ARCHIPOFF, G; LENOBLE, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S88-S91, issn 0160-2446, SUP2Conference Paper

Leukocyte activation study during occlusive arterial disease of the lower limb : effect of pentoxifylline infusionFOSSAT, C; FABRE, D; ALIMI, Y et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S96-S100, issn 0160-2446, SUP2Conference Paper

Leukocyte adherence in an ischemic muscle perfused by a collateral circulationXIN HOU; BAUDRY, N; LENOBLE, M et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S119-S123, issn 0160-2446, SUP2Conference Paper

Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wallBERNARD, C; BARNIER, P.K; MERVAL, R et al.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S30-S33, issn 0160-2446, SUP2Conference Paper

Pharmacologic treatment of venous leg ulcersDORMANDY, J. A.Journal of cardiovascular pharmacology. 1995, Vol 25, pp S61-S65, issn 0160-2446, SUP2Conference Paper